Porras Ana M, Hutson Heather N, Berger Anthony J, Masters Kristyn S
Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, United States.
Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, United States.
Curr Opin Biotechnol. 2016 Aug;40:24-30. doi: 10.1016/j.copbio.2016.02.006. Epub 2016 Feb 27.
Fibrotic diseases occur in virtually every tissue of the body and are a major cause of mortality, yet they remain largely untreatable and poorly understood on a mechanistic level. The development of anti-fibrotic agents has been hampered, in part, by the insufficient fibrosis biomimicry provided by traditional in vitro platforms. This review focuses on recent advancements toward creating 3-D platforms that mimic key features of fibrosis, as well as the application of novel imaging and sensor techniques to analyze dynamic extracellular matrix remodeling. Several opportunities are highlighted to apply new tools from the fields of biomaterials, imaging, and systems biology to yield pathophysiologically relevant in vitro platforms that improve our understanding of fibrosis and may enable identification of potential treatment targets.
纤维化疾病几乎发生在身体的每个组织中,是导致死亡的主要原因,但在很大程度上仍然无法治疗,而且在机制层面上了解甚少。传统体外平台提供的纤维化仿生不足在一定程度上阻碍了抗纤维化药物的开发。本综述重点关注创建模拟纤维化关键特征的三维平台的最新进展,以及应用新型成像和传感技术分析动态细胞外基质重塑。文中强调了利用生物材料、成像和系统生物学领域的新工具来构建具有病理生理学相关性的体外平台的几个机会,这些平台有助于增进我们对纤维化的理解,并可能有助于识别潜在的治疗靶点。